AFC-HD AMS Life Science Co., Ltd.
Regarding capital policy and share exchange policy following Saika-ya’s designation as a monitored stock
As part of the capital policy after Saika-ya's designation as a monitored stock, consideration is being given to a full subsidiary through a share exchange. The definitive share exchange ratio and effective date are undecided, but third-party evaluation and procedures respecting minority shareholders are planned. Going forward, the aim is to maximize value and improve corporate value through asset utilization.
Key Figures
- Share exchange contract signing date: mid-October 2026 (planned)
- Share exchange effective date: around December 2026 (planned)
- Monitored stock designation date: 2026-09-16
AI要約
Section Heading
This IR explains the capital policy and share exchange policy following Saika-ya's designation as a monitored stock. The basic policy is to make Saika-ya a wholly owned subsidiary through a share exchange, using third-party evaluation to determine the share exchange ratio, and clarifying procedures to protect minority shareholders.
Section 2 Heading
Future plans indicate the share exchange contract signing date in mid-October 2026, and the share exchange effective date around December 2026, requiring coordination with relevant authorities. Even after listing is discontinued, the policy is to strengthen Saika-ya's business base and improve corporate value, pursuing capital efficiency and integrated group management.
AFC-HD Amuse Life Sciences
Company overview · Stock price · Financial data · All IR
